McKinley Carter Wealth Services’s NervGen Pharma NGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding NGEN
McKinley Carter Wealth Services's NGEN Position: Q3 2026 in Review
McKinley Carter Wealth Services held its NervGen Pharma (NGEN) position steady in Q3 2026 at 32,653 shares worth $62.4K. The position accounts for ﹤0.01% of the portfolio, ranked #321.
McKinley Carter Wealth Services first reported a position in NGEN in Q1 2026 and has held it in 3 quarters since. The position peaked at $116K in Q1 2026. 68 funds tracked by Wall St. Rank hold NGEN as of Q3 2026.
- McKinley Carter Wealth Services held 32,653 shares of NervGen Pharma worth $62.4K as of Q3 2026.
- McKinley Carter Wealth Services left its NervGen Pharma share count unchanged in Q3 2026.
- NervGen Pharma made up ﹤0.01% of McKinley Carter Wealth Services's portfolio in Q3 2026, its #321 holding.
- McKinley Carter Wealth Services first reported a position in NervGen Pharma in Q1 2026 and has held it in 3 quarters since.
- McKinley Carter Wealth Services's NervGen Pharma position peaked at $116K in Q1 2026.
- 68 funds tracked by Wall St. Rank held NervGen Pharma as of Q3 2026.
Based on McKinley Carter Wealth Services's 13F filing for Q3 2026, filed 16 Oct 2026.